CABOMETYX
Active substance: cabozantinib S-malate
TABLET · CABOZANTINIB S-MALATE 40 mg/1
United StatesActive
Marketing holder: Exelixis, Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- CABOZANTINIB S-MALATE · 40 mg/1
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208d-1697-726e-8a26-30a8808c7d9b,01a1208d-169a-75b4-97aa-1753580978f9,01a12091-8d8d-72c7-be2b-377857e47fc1,01a1209d-5118-78b8-a8c1-3741db5521a0;count=4 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 42388-025
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 42388-025 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 42388-025 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 42388-025 · Verified 2026-10-09 · open in source